Opticrom

Urticaria Pigmentosa, Asthma, Keratoconjunctivitis + 9 more

Treatment

20 Active Studies for Opticrom

What is Opticrom

Cromoglicic acid

The Generic name of this drug

Treatment Summary

Cromolyn is a medication used to prevent asthma attacks. It works by blocking the release of certain chemicals from cells that cause asthma symptoms. Cromolyn can be used to prevent allergies and exercise-induced asthma, but it cannot stop an asthma attack that has already started.

Intal

is the brand name

image of different drug pills on a surface

Opticrom Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Intal

Cromoglicic acid

1982

45

Effectiveness

How Opticrom Affects Patients

Cromoglicate (also known as cromolyn) is a synthetic drug used to treat asthma, allergic rhinitis, conjunctivitis, systemic mastocytosis, and ulcerative colitis. It works by preventing the airways from narrowing during an asthma attack or allergic reaction. It is available as an eye drop and as an oral medication.

How Opticrom works in the body

Cromoglicate reduces the severity of allergic reactions. It does this by blocking the release of histamine and other substances from mast cells. It may also reduce inflammation by blocking calcium from entering the cell.

When to interrupt dosage

The suggested dosage of Opticrom is contingent upon the recognized condition, including Urticaria Pigmentosa, Exercise-Induced Bronchospasm and Conjunctivitis, Vernal. The measure of dosage is reliant upon the technique of delivery (e.g. Liquid; Spray or Respiratory (inhalation)) indicated in the table below.

Condition

Dosage

Administration

Urticaria Pigmentosa

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Asthma

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Keratoconjunctivitis

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Bronchospasm, Exercise-Induced

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Conjunctivitis, Allergic

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Hay Fever

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Seasonal Allergic Conjunctivitis

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Asthma, Exercise-Induced

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Conjunctivitis, Allergic

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Rhinitis, Allergic

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Hypersensitivity

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Food Hypersensitivity

, 20.0 mg/mL, 40.0 mg/mL, 100.0 mg/mL, 5.2 mg/mL, 20.0 mg, 2.0 %, 1.0 %, 100.0 mg, 1.0 mg, 5.2 mg, 1.0 mg/dose, 10.0 mg/mL, 0.04 mg/mg, 1.0 mg/pump actuation

, Oral, Liquid, Liquid - Oral, Ophthalmic, Solution / drops, Solution / drops - Ophthalmic, Intrabronchial, Solution, Solution - Intrabronchial, Solution, concentrate, Solution, concentrate - Oral, Nasal, Spray, metered, Spray, metered - Nasal, Solution - Oral, Concentrate - Oral, Solution - Ophthalmic, Capsule - Oral, Capsule, Respiratory (inhalation), Solution - Respiratory (inhalation), Liquid - Ophthalmic, Liquid - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Aerosol, metered; Solution, Aerosol, metered; Solution - Nasal, Aerosol, metered - Nasal, Powder, Powder - Respiratory (inhalation), Ointment, Ointment - Ophthalmic, Liquid; Spray, Liquid; Spray - Nasal, Spray, Spray - Nasal, Inhalant, Inhalant - Respiratory (inhalation)

Warnings

There are 1 known major drug interactions with Opticrom.

Common Opticrom Drug Interactions

Drug Name

Risk Level

Description

Methacholine

Minor

Cromoglicic acid may decrease effectiveness of Methacholine as a diagnostic agent.

Opticrom Toxicity & Overdose Risk

Overdosing on Sudafed can cause coughing, stuffy nose, nausea, sneezing, and difficulty breathing.

image of a doctor in a lab doing drug, clinical research

Opticrom Novel Uses: Which Conditions Have a Clinical Trial Featuring Opticrom?

157 active clinical trials are currently assessing the effectiveness of Opticrom in providing relief for Asthma, Vernal Keratoconjunctivitis, and Seasonal Allergic Conjunctivitis.

Condition

Clinical Trials

Trial Phases

Asthma

92 Actively Recruiting

Phase 1, Phase 4, Early Phase 1, Phase 2, Not Applicable, Phase 3

Conjunctivitis, Allergic

1 Actively Recruiting

Phase 2

Keratoconjunctivitis

0 Actively Recruiting

Rhinitis, Allergic

0 Actively Recruiting

Food Hypersensitivity

0 Actively Recruiting

Hypersensitivity

0 Actively Recruiting

Urticaria Pigmentosa

0 Actively Recruiting

Bronchospasm, Exercise-Induced

0 Actively Recruiting

Seasonal Allergic Conjunctivitis

0 Actively Recruiting

Conjunctivitis, Allergic

0 Actively Recruiting

Hay Fever

0 Actively Recruiting

Asthma, Exercise-Induced

0 Actively Recruiting

Opticrom Reviews: What are patients saying about Opticrom?

5

Patient Review

2/25/2019

Opticrom for Inflamed Cornea & Conjunctiva of Eye due to Allergies

This product saved me from five or six more days of itchy, inflamed eyes. Within hours of using it, my eyes were back to normal. I'll definitely be keeping a spare bottle on hand from now on!

4.7

Patient Review

11/23/2016

Opticrom for Allergic Conjunctivitis

3

Patient Review

12/19/2019

Opticrom for Giant Papillary Conjunctivitis

It took over a month of using this treatment before I saw any real results, and even then they were slow in coming. Unfortunately, I also developed styes in one of my eyes.

Patient Q&A Section about opticrom

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is opticrom prescription only?

"Opticrom is a drug used to relieve the symptoms of conjunctivitis. It may be used by itself or in combination with other drugs. Mast cell stabilizers are a class of drugs to which Opticrom belongs."

Answered by AI

How many times a day can you use opticrom?

"Using this medicine: -Administer one or two drops into each eye four times daily -Do not use in children under 6 years of age -If you have any questions about using this medicine on a child or if you think the child may have allergic eyes, speak to your doctor or pharmacist."

Answered by AI

How long can you use opticrom eye drops?

"If you are using this medication in only one eye, clean the applicator after each use.

Apply this medication in the affected eye(s), usually 4 times daily or as directed by your doctor. Treatment may be continued for as long as 3 months.

If you are using this medication in only one eye, clean the applicator after each use."

Answered by AI

What is opticrom used for?

"Opticrom Allergy Single Dose 2% w/v Eye Drops, solution is a medicine used to relieve and treat eye allergies in adults and children. The active ingredient is sodium cromoglicate, which belongs to a group of medicines called anti allergics."

Answered by AI

Clinical Trials for Opticrom

Have you considered Opticrom clinical trials?

We made a collection of clinical trials featuring Opticrom, we think they might fit your search criteria.
Go to Trials
Image of Allergy Immunology Associates in Mayfield Heights, United States.

Osteopathic Manipulative Treatment for Asthma

18 - 60
All Sexes
Mayfield Heights, OH

Asthma is a common respiratory condition that can be difficult to control despite the use of medications such as inhalers, oral steroids or even injectable medications. Osteopathic Manipulative Treatment (OMT) is a hands-on technique used to improve the chest structure and function and may help in improving breathing. Previous research showed that OMT in asthma patients, can improve the movement of the ribs and improve the "peak flow" which is the maximum rate at which a person can exhale air after taking a deep breath. However, no studies have evaluated the impact of OMT on lung inflammation. This single-site research study at University Hospitals aims to evaluate whether Osteopathic Manipulative Treatment (OMT) can reduce lung inflammation and improve breathing and lung function in adult patients with asthma. The lung function will be evaluated by Spirometry which is a test that measures how much air you can breathe in and out of your lungs, as well as how quickly and easily you can exhale air. The lung inflammation will be measured using a device that can detect how much you are breathing out Nitric Oxide which is a gas produced by inflamed cells in the lungs, this test is called: Fractional exhaled Nitric Oxide or FeNO. Approximately 100 participants will be enrolled.

Waitlist Available
Has No Placebo

Allergy Immunology Associates

Nancy Wasserbauer-Kingston, DO

Image of DARTNet Institute in Aurora, United States.

Inhaled Corticosteroids + Azithromycin for Asthma

13 - 75
All Sexes
Aurora, CO

While asthma therapy is becoming more individualized based on asthma phenotypes, more research is needed to tailor newer therapies to individuals. Inhaled corticosteroid (ICS) medications are the foundation of care for all individuals with persistent asthma. But ICS use is not without possible long term side effects. This study will compare two currently available approaches to reduce AEX in primary care patients: (1) use of inhaled corticosteroids (ICS) as part of rescue therapy, also known as MART (Maintenance And Reliever Therapy) or PARTICS (Patient Activated Reliever Trigger Inhaled Corticosteriods) therapy - either of these therapies will be called Rescue-Inhaled Corticosteroids or R-ICS pronounced "Ricks," and (2) use of azithromycin (AZ) as a preventive therapy. These treatments will be studied both individually and in combination.

Phase 4
Recruiting

DARTNet Institute (+12 Sites)

Wilson D Pace, MD, FAAFP

Have you considered Opticrom clinical trials?

We made a collection of clinical trials featuring Opticrom, we think they might fit your search criteria.
Go to Trials
Image of Velocity Clinical Research, Mobile in Mobile, United States.

PF-07275315 for Asthma

18 - 70
All Sexes
Mobile, AL

The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, which negatively impacts the quality of life and functioning of people who are affected. This study is seeking participants who: * Are 18 to 70 years old * Have had moderate-to-severe asthma for at least 12 months that is not well controlled * Have been taking their regular maintenance treatment(s) for asthma over the last 12 months All participants will receive PF-07275315 or a placebo. A placebo does not have any medicine in it but looks just like the medicine being studied. PF-07275315 or placebo will be given as multiple shots in the clinic over the course of 12 weeks. We will compare the experiences of people receiving PF-07275315 to those of the people who do not. This will help us determine if PF-07275315 is safe and effective. Participants will be involved in this study for about 9.5 months. During this time, they will have 10 visits at the study clinic.

Phase 2
Recruiting

Velocity Clinical Research, Mobile (+10 Sites)

Pfizer CT.gov Call Center

Pfizer

Image of St. Joseph's Healthcare Hamilton in Hamilton, Canada.

Corticosteroids for Asthma

18+
All Sexes
Hamilton, Canada

Most individuals with asthma can effectively manage their symptoms and maintain normal lung function using inhaled medications, unfortunately, there is a subset of asthma sufferers whose symptoms, lung function, and risk of asthma attacks remain unimproved despite conventional inhaled medications. There could be several reasons for this. One possibility is that inhaled medications fail to reach the intended areas within the lungs, due to structural abnormalities within the airways themselves. Much like road conditions or closures can impede the speed and efficiency of vehicle travel, factors such as airway narrowing or mucus blockages, which are common in asthma, can obstruct the passage of inhaled medications through the airways. Our team has now optimized advanced medical imaging techniques, including magnetic resonance imaging (MRI) and computed tomography (CT), required to investigate this. This study will use these imaging methods to visually assess and measure individual patients' airways and determine whether abnormal airway structures impact how well they respond to inhaled and orally delivered medications. We anticipate finding that abnormal airway structures make inhaled medications less effective, but that they do not affect the response to oral medications.

Phase 4
Recruiting

St. Joseph's Healthcare Hamilton (+1 Sites)

Have you considered Opticrom clinical trials?

We made a collection of clinical trials featuring Opticrom, we think they might fit your search criteria.
Go to Trials